Step 1: Initiate Change Control for Labeling Update

The labeling update process begins with formal change control:

• ✅ Register a change control number in your QMS
• ✅ Define the scope: which products, SKUs, and regions are affected
• ✅ Link the change to approved stability extension documentation
• ✅ Assign cross-functional team (Regulatory, QA, Artwork, Packaging)

Documentation from this step ensures traceability and supports compliance with GMP guidelines.

Step 2: Identify All Affected Label Components

Labeling in pharma extends beyond cartons. Key components include:

• 📌 Primary label (vial, blister, bottle)
• 📌 Secondary packaging (outer box)
• 📌 Patient information leaflet (PIL)
• 📌 Summary of Product Characteristics (SmPC)
• 📌 Serialization and e-leaflet systems

Review the latest artwork versions in your internal labeling system or with vendors to plan revisions accordingly.

Step 3: Prepare Revised Label Content

Prepare the new label content with updated expiry information:

• ✅ Update shelf life duration (e.g., 24 months to 36 months)
• ✅ Adjust associated storage conditions if changed (e.g., “store below 30°C”)
• ✅ Review if expiry format (MM/YYYY) remains valid
• ✅ Revise batch release SOP references for consistency

Ensure regulatory accuracy and use only approved standard phrases.

Step 4: Generate Mock-Ups and Artwork

After content finalization, generate updated artwork files or mock-ups:

• ✅ Use validated artwork management software or vendors
• ✅ Cross-check barcodes, fonts, and expiry layout
• ✅ Maintain version control for comparison
• ✅ Add watermarks on draft mock-ups to avoid misprinting

This step is essential for approvals, especially in regulated markets like EU and US.

Step 5: Submit Regulatory Labeling Variation

The regulatory submission pathway depends on region:

• USFDA: Include updated labeling in a CBE-30 or PAS filing
• EMA: Type IB/II variation including Module 1.3 and 1.3.1 updates
• CDSCO: Submit updated labels with Form 44 and summary cover letter
• Other markets: Use local health authority portals or variation processes

Refer to dossier submission best practices to avoid variation rejection.

Step 6: Regulatory Review and Approval Process

Once submitted, agencies may request clarification on:

• 📝 Format and justification for expiry update
• 📝 Compatibility with shelf life data submitted
• 📝 Impact on storage instructions or warnings
• 📝 Updates in patient safety sections (if applicable)

Prepare a query response team and document all communication for audit readiness.

Step 7: Internal Approval and QA Release

• ✅ Review mock-ups internally with QA and Regulatory
• ✅ Approve via formal internal document control system
• ✅ Ensure batch release SOP is updated with new labels
• ✅ Archive old and new labels in a controlled system

Label approval should align with change control closure and product release planning.

Step 8: Coordinate with Manufacturing and Distribution

Rollout strategy must include:

• ✅ Recalling or relabeling stock if required
• ✅ Ensuring suppliers and third parties receive updates
• ✅ Updating serialization records with new expiry
• ✅ Informing warehouse for shelf sticker replacements

Refer to SOP writing in pharma for detailed control procedures.

Step 9: Train Stakeholders

Conduct training sessions for:

• ✅ Regulatory and QA personnel
• ✅ Packaging and warehouse teams
• ✅ Distribution partners and sales force (if needed)
• ✅ Pharmacovigilance (to assess if expiry affects safety reporting)

Use updated SOPs and include quizzes or acknowledgment forms for documentation.

Step 10: Post-Approval Monitoring and Audit Readiness

• ✅ Verify that new labels are in use across all product lines
• ✅ Conduct internal audits to check implementation accuracy
• ✅ Maintain records of mock-ups, submission approvals, and stakeholder training
• ✅ Be prepared for regulatory inspections covering labeling changes

Maintain a centralized labeling master file for each product as part of QA documentation.

Conclusion

Labeling updates following a shelf life extension are more than cosmetic changes—they reflect the regulatory and scientific integrity of your product lifecycle. By following this structured, step-by-step approach, pharma professionals can ensure global compliance, patient safety, and product availability without delay.

References:

• EMA Labeling Variation Guide
• GMP compliance for labeling control
• Labeling variation submission
• Pharma SOPs for label change
• FDA Labeling Requirements

Why This Checklist Matters

Labeling errors involving shelf life and expiry are among the most frequently cited issues during GMP audits. The consequences range from market withdrawal to patient risk. A robust internal checklist helps mitigate such risks by offering a standardized approach for cross-departmental teams.

This checklist is divided into stages, from pre-approval documentation to commercial packaging release.

Stage 1: Pre-Approval Label Planning

Ensure that regulatory, QA, and packaging teams agree on how shelf life and expiry will be communicated before commercial launch.

• Confirm shelf life assignment from ICH Q1A-compliant stability studies
• Define expiry as the outer boundary of validated shelf life
• Align label text with CTD modules (Modules 1.3 and 3.2.P.8.1)
• Include shelf life justification in product development reports
• Plan label format based on country-specific regulatory preferences

Proactive agreement at this stage avoids late-stage delays during submission or launch.

Stage 2: Label Design and Artwork Review

This phase involves formatting the label text, choosing expiry date placement, and verifying against local authority rules.

• Expiry date formatted as “MM/YYYY” unless otherwise required
• Include “Do not use after…” for OTC or patient-facing labels
• Ensure font size and contrast are legible as per local regulations
• Use consistent terminology across multilingual labels
• Verify packaging component (carton, bottle, blister) match artwork master

In jurisdictions like the EU, additional labeling elements may be needed per EMA guidelines.

Stage 3: Manufacturing and Batch Record Alignment

The expiry printed on labels must be traceable to the batch manufacture date and ERP system entries.

• Confirm Manufacture Date in BMR matches ERP-generated label
• Auto-calculate expiry based on validated shelf life (e.g., 24 months)
• Cross-check expiry in batch release documentation
• Ensure GMP compliance in label issuance and printing SOPs
• Audit trail maintained for label revision and batch-specific changes

Discrepancies between ERP, label, and CoA are common audit findings and must be avoided.

Stage 4: Label Printing and QA Review

Final packaging labels must be reviewed and approved by QA before market release.

• Label includes batch number, Mfg. Date, and Exp. Date clearly
• Review printed samples against approved artwork file
• Perform label reconciliation after printing
• Lock expiry field in printing software to prevent manual override
• Maintain signed approval records for every lot-specific label

Including QA in the loop ensures traceability and compliance with CDSCO or other local regulations.

Stage 5: Post-Release Label Verification

After product dispatch, ongoing verification ensures labels in the market match intended shelf life and expiry declarations.

• Conduct market sample inspections periodically
• Cross-verify expiry in distribution documentation
• Revalidate expiry alignment after any change control implementation
• Document feedback or issues from field teams or customers
• Conduct mock recall exercises involving label traceability

This step is vital in maintaining confidence across the supply chain and during regulatory inspections.

Stage 6: Handling Label Changes After Shelf Life Extension

Sometimes, based on new stability data or reformulation, shelf life may be extended. This demands robust change control and relabeling protocols.

• Obtain regulatory approval before implementing new expiry dates
• Update stability summary reports and CoA accordingly
• Ensure updated expiry date is reflected in all packaging lines
• Train packaging team on revised expiry handling
• Record all change actions in the QMS (Quality Management System)

Relabeling errors post-extension are a common pitfall without strict checklist adherence.

Common Mistakes to Avoid in Expiry-Based Labeling

• Printing expiry that doesn’t align with approved shelf life
• Misalignment between ERP and printed packaging
• Labeling based on proposed, not approved, shelf life
• Omitting expiry from primary pack where required
• Using inconsistent formats like “best before” or “use by” interchangeably with expiry

Training cross-functional teams on these errors reduces the risk of regulatory citations and batch recalls.

Cross-Functional Responsibilities in Label Compliance

Ensuring correct labeling is a team effort involving QA, Regulatory Affairs, Production, and Packaging. Here’s how roles are distributed:

Regular team coordination is essential to ensure expiry information stays consistent and compliant across all outputs.

Conclusion

When it comes to pharmaceutical labeling, attention to detail is critical—especially for shelf life and expiry dates. This checklist ensures that every stakeholder, from regulatory affairs to production, adheres to globally accepted practices for labeling accuracy.

Incorporating this checklist into daily operations helps ensure regulatory readiness, patient safety, and internal alignment. By making expiry compliance a cross-functional habit, pharma companies can confidently navigate global markets and reduce the risk of costly errors.

References:

• ICH Q1A(R2) Stability Guidelines
• USFDA Labeling Compliance
• EMA Packaging Guidelines
• CDSCO Schedule M Labeling Rules